Physician profile
Eric K Fowler
NPI 1740217611
$5,551.54
in general payments reported to CMS, 2019-2025
40 companies · $1,098 in 2025
The $1,098 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,674 · 2020: $651 · 2021: $253 · 2022: $501 · 2023: $598 · 2024: $777 · 2025: $1,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $928.82 | 2019-2025 | |
| Glaxosmithkline, LLC. | $718.49 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $618.93 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $478.82 | 2019-2024 | Jardiance, Zepbound, Mounjaro |
| Abbvie INC. | $326.76 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $281.46 | 2019-2025 | Airsupra, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.04 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.90 | 2019-2025 | Jardiance, Synjardy |
| Abbott Laboratories | $186.99 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $174.74 | 2019-2020 | |
| Exact Sciences Corporation | $151.83 | 2024-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $146.99 | 2020-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $125.70 | 2019-2023 | Spravato |
| Amgen INC. | $96.61 | 2019-2025 | Evenity, Prolia |
| Eisai INC. | $90.75 | 2024-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.